Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetics of Meropenem Across the Adult Lifespan.
Boutzoukas AE, Balevic SJ, Hemmersbach-Miller M, Winokur PL, Gu K, Chan AW, Cohen-Wolkowiez M, Conrad T, An G, Kirkpatrick CMJ, Swamy GK, Walter EB, Schmader KE, Landersdorfer CB. Boutzoukas AE, et al. Among authors: landersdorfer cb. Clin Pharmacokinet. 2024 Dec 16. doi: 10.1007/s40262-024-01465-1. Online ahead of print. Clin Pharmacokinet. 2024. PMID: 39681779
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan.
Hemmersbach-Miller M, Balevic SJ, Winokur PL, Landersdorfer CB, Gu K, Chan AW, Cohen-Wolkowiez M, Conrad T, An G, Kirkpatrick CMJ, Swamy GK, Walter EB, Schmader KE. Hemmersbach-Miller M, et al. Among authors: landersdorfer cb. Clin Pharmacokinet. 2023 Jan;62(1):127-139. doi: 10.1007/s40262-022-01198-z. Epub 2023 Jan 12. Clin Pharmacokinet. 2023. PMID: 36633812 Free PMC article.
Population Pharmacokinetics of Moxifloxacin in Children.
Greenberg RG, Landersdorfer CB, Rivera-Chaparro N, Harward M, Conrad T, Nakamura A, Kirkpatrick CM, Gu K, Ghazaryhan V, Osborn B, Walter EB. Greenberg RG, et al. Among authors: landersdorfer cb. Paediatr Drugs. 2022 Mar;24(2):163-173. doi: 10.1007/s40272-022-00493-3. Epub 2022 Mar 14. Paediatr Drugs. 2022. PMID: 35284983 Free PMC article.
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.
An G, Creech CB, Wu N, Nation RL, Gu K, Nalbant D, Jimenez-Truque N, Fissell W, Rolsma S, Patel PC, Watanabe A, Fishbane N, Kirkpatrick CMJ, Landersdorfer CB, Winokur P. An G, et al. Among authors: landersdorfer cb. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0131222. doi: 10.1128/aac.01312-22. Epub 2023 Jan 9. Antimicrob Agents Chemother. 2023. PMID: 36622154 Free PMC article.
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
An G, Creech CB, Wu N, Nation RL, Gu K, Nalbant D, Jimenez-Truque N, Fissell W, Patel PC, Fishbane N, Watanabe A, Rolsma S, Kirkpatrick CMJ, Landersdorfer CB, Winokur P. An G, et al. Among authors: landersdorfer cb. J Antimicrob Chemother. 2023 Jun 1;78(6):1460-1470. doi: 10.1093/jac/dkad106. J Antimicrob Chemother. 2023. PMID: 37071586 Free PMC article.
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis.
Rolsma SL, Sokolow A, Patel PC, Sokolow K, Jimenez-Truque N, Fissell WH, Ryan V, Kirkpatrick CM, Nation RL, Gu K, Teresi M, Fishbane N, Kontos M, An G, Winokur P, Landersdorfer CB, Creech CB. Rolsma SL, et al. Among authors: landersdorfer cb. J Infect Dis. 2024 Sep 30:jiae451. doi: 10.1093/infdis/jiae451. Online ahead of print. J Infect Dis. 2024. PMID: 39344185
Utilizing an Opportunistic Clinical Study and Population-Based Pharmacokinetic Models to Identify Rational Empiric Dosing Regimens for Piperacillin-Tazobactam in Critically Ill Patients.
Reeder JA, Creech CB, Nation RL, Gu K, Nalbant D, Wu N, Jimenez-Truque N, Fissell W, Rolsma SL, Fishbane N, Kirkpatrick CMJ, Patel PC, Watanabe A, Landersdorfer CB, Winokur P, An G. Reeder JA, et al. Among authors: landersdorfer cb. J Clin Pharmacol. 2024 Dec 3. doi: 10.1002/jcph.6161. Online ahead of print. J Clin Pharmacol. 2024. PMID: 39628093
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.
Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB. Bergen PJ, et al. Among authors: landersdorfer cb. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02642-16. doi: 10.1128/AAC.02642-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28264846 Free PMC article.
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.
Agyeman AA, Rogers KE, Tait JR, Bergen PJ, Kirkpatrick CM, Wallis SC, Bulitta JB, Paterson DL, Lipman J, Nation RL, Roberts JA, Landersdorfer CB. Agyeman AA, et al. Among authors: landersdorfer cb. Clin Pharmacol Ther. 2021 Apr;109(4):1104-1115. doi: 10.1002/cpt.2191. Epub 2021 Mar 12. Clin Pharmacol Ther. 2021. PMID: 33550617
139 results